These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7150772)

  • 21. Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells.
    Lattime EC; Pecoraro GA; Stutman O
    J Immunol; 1981 May; 126(5):2011-4. PubMed ID: 7217680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T; Tanino T; Egawa K
    Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Destruction of murine lymphoma cells by allogeneic peritoneal macrophages in vitro: influence of antiserum.
    Dingemans KP; Pels E; van Dongen G; den Otter W
    J Natl Cancer Inst; 1983 Jan; 70(1):181-92. PubMed ID: 6571913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat NK cells active against lymphoma and sarcoma tumor cells are probably identical.
    Brooks CG; Flannery GR; Cantrell DA; Gray JD; Robins RA; Baldwin RW
    J Immunol; 1982 Feb; 128(2):913-9. PubMed ID: 6976388
    [No Abstract]   [Full Text] [Related]  

  • 27. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
    Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
    Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines.
    Salem ML
    Int Immunopharmacol; 2005 Jun; 5(6):947-60. PubMed ID: 15829411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired induction of type II interferon in tumor-bearing mice.
    Matsubara S; Suzuki M; Ishida N
    Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol.
    Kalland T; Forsberg JG
    Cancer Res; 1981 Dec; 41(12 Pt 1):5134-40. PubMed ID: 7307011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity.
    Kim YS; Sonn CH; Paik SG; Bothwell AL
    Gene Ther; 2000 May; 7(10):837-43. PubMed ID: 10845721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of calf thymus gangliosides on the activity of natural killer cells in mice].
    Fuks BB; Sterlina AG; Sinitsyna EV; Diatlovitskaia EV; Bergel'son LD
    Dokl Akad Nauk SSSR; 1983; 270(1):254-6. PubMed ID: 6884178
    [No Abstract]   [Full Text] [Related]  

  • 34. LYT-2 negative and T cell growth factor independent cytotoxic T lymphocyte hybridomas.
    Kaufmann Y
    Adv Exp Med Biol; 1982; 146():435-46. PubMed ID: 6980569
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective reduction of human tumor cell populations by human granulocytes in vitro.
    Chee DO; Townsend CM; Galbraith MA; Eilber FR; Morton DL
    Cancer Res; 1978 Dec; 38(12):4534-9. PubMed ID: 569013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.